Literature DB >> 12845346

The evolving epidemiology of Helicobacter pylori infection and gastric cancer.

Jia-Qing Huang1, Richard H Hunt.   

Abstract

The relationship between Helicobacter pylori infection and the risk of gastric cancer has been well established in the last decade. Four meta-analyses have found that the infection increases the risk of noncardia gastric cancer by 2- to 6-fold compared with noninfected control populations. However, the role of cagA strains of H pylori in relation to gastric cancer has not been evaluated systematically. We undertook a meta-analysis of epidemiological studies examining the relationship between infection with cagA-positive strains of H pylori and the risk of gastric cancer, and found that patients who are seropositive for cagA strains of H pylori are at an increased risk for developing noncardia gastric cancer compared with those with H pylori infection alone. Therefore, searching for cagA-positive strains of H pylori may help identify populations at a greater risk for developing gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845346     DOI: 10.1155/2003/692808

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  12 in total

Review 1.  Nontraditional therapies to treat Helicobacter pylori infection.

Authors:  Morris O Makobongo; Jeremy J Gilbreath; D Scott Merrell
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

Review 2.  Multidisciplinary approach to understand the pathogenesis of gastric cancer.

Authors:  Juan Shang; A S Pena
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 3.  Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

Authors:  Min-Min Zhang; Wei Qian; Ying-Yi Qin; Jia He; Yu-Hao Zhou
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.

Authors:  Xiao-Zhong Gao; Xiu-Li Qiao; Wen-Chong Song; Xiao-Feng Wang; Feng Liu
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 5.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a systematic review of recent evidence.

Authors:  Vikram Kate; Raja Kalayarasan; Nilakantan Ananthakrishnan
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

6.  Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.

Authors:  Giuseppe Scaccianoce; Cesare Hassan; Alba Panarese; Donato Piglionica; Sergio Morini; Angelo Zullo
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

Review 7.  Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.

Authors:  Iris Lansdorp-Vogelaar; Linda Sharp
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-09-27       Impact factor: 3.043

8.  Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.

Authors:  Ying-Qun Zhou; Ling Xu; Bing-Fang Wang; Xiao-Ming Fan; Jian-Ye Wu; Chun-Yan Wang; Chuan-Yong Guo; Xuan-Fu Xu
Journal:  Gastroenterol Res Pract       Date:  2011-11-21       Impact factor: 2.260

Review 9.  Effect of coffee consumption on the risk of gastric cancer: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Haibin Liu; Ying Hua; Xiangyun Zheng; Zhaojun Shen; Hui Luo; Xuejiao Tao; Zhiyi Wang
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 10.  Advances in the treatment of Helicobacter pylori infection in children.

Authors:  Nicolas Kalach; Patrick Bontems; Samy Cadranel
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.